The dual role of HMGB1 in pancreatic cancer
Journal of Pancreatology · 2018
DOI: 10.1097/jp9.0000000000000002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pancreatology, 2018. Verfasst von Rui Kang und 1 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of exocrine pancreatic cancer with a 9% 5-year survival rate. High mobility group box 1 (HMGB1) is a nuclear protein that can act as a DNA chaperone in the sustainment of chromosome structure and function. When released into the extracellular space, HMGB1 becomes the most well characterized damage-associated molecular pattern (DAMP) to trigger immune responses. Recent evidence indicates that intracellular HMGB1 is a novel tumor suppressor in PDAC, which is connected to its role in the prevention of oxidative stress, genomic instability, and histone release. However, since extracellular HMGB1 is a DAMP and proinflammatory cytokine, cancer cells can also exploit it to survive through the receptor for advanced glycation endproducts (RAGE) in the pancreatic tumor microenvironment. Interestingly, targeting the HMGB1-RAGE pathway has become a new anti-cancer therapy strategy for PDAC.
Zitieren
APA
Kang, R., & Tang, D. (2018). The dual role of HMGB1 in pancreatic cancer. Journal of Pancreatology. https://doi.org/10.1097/jp9.0000000000000002
Vancouver
Kang R, Tang D. The dual role of HMGB1 in pancreatic cancer. Journal of Pancreatology. 2018. doi:10.1097/jp9.0000000000000002
BibTeX
@article{Kang2018,
author = {Kang, Rui and Tang, Daolin},
title = {The dual role of HMGB1 in pancreatic cancer},
journal = {Journal of Pancreatology},
year = {2018},
doi = {10.1097/jp9.0000000000000002}
}
EUVIMED